Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection

World Journal of Gastroenterology

Volumn 9, Issue 4, 2003, Pages 641-644

  Wang, Fu Sheng ^a  

^a Beijing Institute of Infectious Diseases   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CHEMOKINE; COMPLEMENT COMPONENT C4; CYTOCHROME P450; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; MANNOSE BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ACUTE HEPATITIS; ALLELE; ANTIBIOTIC RESISTANCE; CHRONIC HEPATITIS; EFFECTOR CELL; GENE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEREDITY; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; OUTCOMES RESEARCH; PATHOGENESIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL; VERTICAL TRANSMISSION; VIROLOGY; VIRUS CARRIER; VIRUS RESISTANCE;

EID: 0037963186     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i4.641     Document Type: Review

References (44)

1. Gu CH, Luo KX. Hepatitis B: Basic Biology and Clinical Science. Second Edition. Beijing, People's Medical Publishing House 2001: 1-6
2. Iino S. Natural history of hepatitis B and C virus infections. Oncology 2002; 62(Suppl 1): 18-23
3. Luo KX. Hepatitis B: Basic Biology and Clinical Science. Second Edition. Beijing, People's Medical Publishing House 2001: 56-70
4. Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29-60
5. Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19: 65-91
6. Abel L, Dessein AJ. The impact of host genetics on susceptibility to human infectious diseases. Curr Opin Immunol 1997; 9: 509-516
7. McNicholl J. Host genes and infectious diseases. Emerg Infect Dis 1998; 4: 423-426
8. McNicholl JM, Cuenco KT. Host genes and infectious diseases. HIV, other pathogens, and a public health perspective. Am J Prev Med 1999; 16: 141-154
9. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-510
10. Dean M, Carrington M, O'Brien SJ. Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet 2002; 3: 263-292
11. Hill AV. Host genetics of infectious diseases: Old and new approaches converge. Emerg Infect Dis 1998; 4: 695-697
12. Hill AV. The immunogenetics of human infectious diseases. Annu Rev Immunol 1998; 16: 593-617
13. Thio CL, Thomas DL, Carrington M. Chronic viral hepatitis and the human genome. Hepatology 2000; 31: 819-827
14. Kwiatkowski D. Genetic dissection of the molecular pathogenesis of severe infection. Intensive Carc Med 2000; 26(Suppl 1): S89-97
15. Weatherall D, Clegg J, Kwiatkowski D. The role of genomics in studying genetic susceptibility to infectious disease. Genome Research 1997; 7: 967-973
16. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, Purdie DM, Jonsson JR. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 2000; 31: 828-833
17. Hohler T, Gerken G, Notghi A, Lubjuhn R, Taheri H, Protzer U, Lohr HE, Schneider PM, Meyer Zum Buschenfelde KH, Rittner C. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol 1997; 26: 503-507
18. Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2002; 2: 560-567
19. Knolle PA, Kremp S, Hohler T, Krummenauer F, Schirmacher P, Gerken G. Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up. J Viral Hepat 1998; 5: 399-406
20. Abel L, Dessein AJ. Genetic epidemiology of infectious diseases in humans: Design of population-based studies. Emerg Infect Dis 1998; 4: 593-603
21. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet 1999; 344: 1194-1195
22. Zavaglia C, Bortolon C, Ferrioli G, Rho A, Mondazzi L, Bottelli R, Ghessi A, Gelosa F, Iamoni G, Ideo G. HLA typing in chronic type B, D and C hepatitis. J Hepatol 1996; 24: 658-665
23. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995; 332: 1065-1069
24. Thursz MR. Host genetic factors influencing the outcome of hepatitis. J Viral Hepat 1997; 4: 215-220
25. Thio CL, Carrington M, Marti D, O'Brien SJ, Vlahov D, Nelson KE, Astemborski JA, Thomas DL. Class II of HLA alleles and hepatitis B Virus persistence African Americans. J Infect Dis 1999; 179: 1004-1006
26. Diepolder HM, Jung MC, Keller E, Schraut W, Gerlach JT, Gruner N, Zachoval R, Hoffmann RM, Schirren CA, Scholz S, Pape GR. A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol 1998; 113: 244-251
27. Ahn SH, Han KH, Park JY, Lee CK, Kang SW, Chon CY, Kim YS, Park K, Kim DK, Moon YM. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 2000; 31: 1371-1373
28. Westendorp RG, Langermans JA, Huizinga TW, Verweij CL, Sturk A. Genetic influence on cytokine production in meningococcal disease. Lancet 1997; 349: 1912-1913
29. Van Deventer SJ. Cytokine and cytokine receptor polymorphisms in infectious disease. Intensive Care Med 2000; 26(Suppl 1): S98-S102
30. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444-3451
31. Knight JC, Kwiatkowski D. Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proc Assoc Am Physicians 1999; 111: 290-298
32. Hajeer AH, Hutchinson IV. TNF-alpha gene polymorphism: Clinical and biological implications. Microsc Res Tech 2000; 50: 216-228
33. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998; 51: 605-612
34. Miyazoe S, Hamasaki K, Nakata K, Kajiya Y, Kitajima K, Nakao K, Daikoku M, Yatsuhashi H, Koga M, Yano M, Eguchi K. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol 2002; 97: 2086-2092
35. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer Zum Buschenefelde KH, Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 1998; 111: 579-582
36. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer Zum Buschenfelde KH, Rittner C. Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection. J Med Virol 1998; 54: 173-177
37. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 1999; 30: 526-530
38. Thomas HC, Foster GR, Sumiya M, McIntosh D, Jack DL, Turner MW, Summerfield JA. Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection. Lancet 1996; 348: 1417-1419
39. Yuen MF, Lau CS, Lau YL, Wong WM, Cheng CC, Lai CL. Mannose binding lectin gene mutations are associated with progression of liver disease in chronic hepatitis B infection. Hepatology 1999; 29: 1248-1251
40. Hohler T, Wunschel M, Gerken G, Schneider PM, Meyer Zum Buschenfelde KH, Rittner C. No association between mannose-binding lectin alleles and susceptibility to chronic hepatitis B virus infection in German patients. Exp Clin Immunogenet 1998; 15: 130-133
41. Bellamy R, Hill AV. Genetic susceptibility to mycobacteria and other infectious pathogens in humans. Curr Opin Immunol 1998; 10: 483-487
42. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273: 1856-1862
43. Griffiths PD. Interactions between viral and human genes. Rev Med Virol 2002; 12: 197-199
44. Dean M, Carrington M, O'Brien SJ. Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet 2002; 3: 263-292